Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014
July 28 2014 - 9:00AM
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields
of cancer metabolism and inborn errors of metabolism, today
announced that it will host a conference call and live webcast on
Thursday, August 7, 2014 at 8:30 a.m. EDT to report its second
quarter 2014 financial results and discuss recent business
activities.
The live webcast can be accessed under "Events &
Presentations" in the Investors and Media section of the company's
website at www.agios.com. The conference call can be accessed by
dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international)
and refer to conference ID 78621204. The webcast will be archived
and available for replay on the company's website beginning
approximately two hours after the event.
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is focused on discovering and developing
novel drugs to treat cancer and inborn errors of metabolism, or
IEMs, which are rare genetic metabolic diseases, through scientific
leadership in the field of cellular metabolism. In addition to an
active research and discovery pipeline across both therapeutic
areas, Agios has multiple first-in-class lead product candidates in
cancer metabolism and IEMs in clinical and/or preclinical
development. All Agios programs focus on genetically identified
patient populations, leveraging our knowledge of metabolism,
biology and genomics. For more information, please visit our
website at www.agios.com.
CONTACT: Agios Pharmaceuticals:
Lora Pike
Senior Director, Investor Relations and Public Relations
investors@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2023 to Apr 2024